Lupus & antiphospholipid syndrome

Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study

LupusPublished Prospective cohort study

Authors' conclusion

Mild cognitive impairment is prevalent among patients with SLE.

Study context

Population
Patients with systemic lupus erythematosus (SLE), April 2021 to March 2022 (median age 44 years; 96% female)173 completed 6-month re-evaluation
Participants
200 patients
Outcome
Prevalence of cognitive impairment (Montreal Cognitive Assessment (MoCA); for Thais, 17-24 mild, ≤16 severe) and cognitive changes after 6 months
Follow-up
6 months
Methodological details6-month follow-up, multivariate analysis
  • 6-month follow-up
  • Multivariate analysis

Main finding

As reported in the abstract

Cognitive impairment (MoCA) at baseline

Cognitive impairment

70%

Mild cognitive impairment

63%

Severe cognitive impairment

7%

Observational data: associations, not effects.

Further findings

Factors associated with cognitive impairment

OR (95% CI)
Age > 40 yearsMultivariate analysis3.71 (1.72–8.00)
Formal education < 12 yearsMultivariate analysis3.11 (1.45–6.63)
Prednisolone useMultivariate analysis2.21 (1.08–4.51)

Most often affected domains · baseline

Delayed recall
82%
Abstraction
80.5%
Language
76%
Visuospatial/executive function
70.5%
Orientation and naming least involved

Cognitive changes at 6-month re-evaluation (173 patients)

Any cognitive change
66 (38.2%)
Improved
52 [30.1%]
Deteriorated
14 [8.1%]
All commonly affected domains except delayed recall significantly improved
Disease activity, prednisolone, antimalarial or immunosuppressant use did not predict cognitive improvement

Original publication

Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study. Lupus. Published 17 August 2023. doi:10.1177/09612033231196215

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.